A Comprehensive Review of Hypertension in Pregnancy
暂无分享,去创建一个
Reem Mustafa | Anuragini Gupta | R. Venuto | Reem Mustafa | Sana Ahmed | Anu Gupta | Rocco C. Venuto | Sana Ahmed
[1] I. Sargent,et al. Immunology of Normal Pregnancy and Preeclampsia , 2009 .
[2] L. Magee,et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. , 2014, Pregnancy hypertension.
[3] C. Homer,et al. Predicting Transformation from Gestational Hypertension to Preeclampsia in Clinical Practice: A Possible Role for 24 Hour Ambulatory Blood Pressure Monitoring , 2007, Hypertension in pregnancy.
[4] A. Morrison,et al. Allelic variations in angiogenic pathway genes are associated with preeclampsia. , 2009, American journal of obstetrics and gynecology.
[5] A. Korda,et al. Clonidine hydrochloride‐A safe and effective antihypertensive agent in pregnancy , 1985, Obstetrics and gynecology.
[6] T. Leivestad,et al. Preeclampsia and the risk of end-stage renal disease. , 2008, The New England journal of medicine.
[7] S. Vreeburg,et al. Hypertension during pregnancy in South Australia, Part 2: Risk factors for adverse maternal and/or perinatal outcome – results of multivariable analysis , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.
[8] M. Brown,et al. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. , 2002, American journal of obstetrics and gynecology.
[9] A. Decherney,et al. Relaxin , 1960, Nature.
[10] I. Greer,et al. Manifestations of chronic disease during pregnancy. , 2005, JAMA.
[11] H. Stenlund,et al. Long-term Impact of Reproductive Factors on the Risk of Cervical, Endometrial, Ovarian and Breast Cancer , 2001, Acta oncologica.
[12] G. Koren,et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. , 1996, American journal of obstetrics and gynecology.
[13] K. Newton,et al. Preeclampsia and Risk of Developing Subsequent Diabetes , 2009, Hypertension in pregnancy.
[14] L. Magee,et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis , 2003, BMJ : British Medical Journal.
[15] B. Sibai,et al. Chronic hypertension in pregnancy. , 1991, Obstetrics and gynecology clinics of North America.
[16] B. Sibai,et al. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term , 1987, Obstetrics and gynecology.
[17] P. McKenzie,et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. , 2007, Kidney international.
[18] Sanjeev G Shroff,et al. Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. , 2006, Endocrinology.
[19] E. Lieberman,et al. Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. , 2001, American journal of obstetrics and gynecology.
[20] R. Romero,et al. Tests to Predict Preeclampsia , 2009 .
[21] L. Beilin,et al. TREATMENT OF HYPERTENSION IN PREGNANCY WITH METHYLDOPA: BLOOD PRESSURE CONTROL AND SIDE EFFECTS , 1977, British journal of obstetrics and gynaecology.
[22] S. Montán,et al. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. , 1993, American journal of obstetrics and gynecology.
[23] R K Craig,et al. Methods in molecular medicine. , 1987, British medical journal.
[24] Christopher P Price,et al. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. , 2005, Clinical chemistry.
[25] Joshua R. Smith,et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[26] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.
[27] G. H. Lambert,et al. Transfer of drugs and other chemicals into human milk. , 2001, Pediatrics.
[28] A. Hingorani,et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[29] S. Y. Park,et al. Effective Prediction of Preeclampsia by a Combined Ratio of Angiogenesis-Related Factors , 2008, Obstetrics and gynecology.
[30] A. Coomarasamy,et al. Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic review , 2006, BJOG : an international journal of obstetrics and gynaecology.
[31] J. Creeden,et al. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective , 2010, Journal of medical economics.
[32] J. Laragh,et al. Hypocalciuria in preeclampsia. , 1987, The New England journal of medicine.
[33] A. Makris,et al. Postpartum hypertension and nonsteroidal analgesia. , 2004, American journal of obstetrics and gynecology.
[34] Donna D. Johnson,et al. Soluble endoglin as a second-trimester marker for preeclampsia. , 2007, American journal of obstetrics and gynecology.
[35] Robert N. Taylor,et al. Endothelial Cell Dysfunction and Oxidative Stress , 2009 .
[36] S. Crawford,et al. Soluble Endoglin for the Prediction of Preeclampsia in a High Risk Cohort , 2010, Hypertension in pregnancy.
[37] A. Odutayo,et al. The kidney in normal pregnancy and preeclampsia. , 2011, Seminars in nephrology.
[38] J. Granger,et al. Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression , 2009, Hypertension.
[39] J. Davison,et al. The renal response to preeclampsia. , 2004, Seminars in nephrology.
[40] T. Kiran,et al. Is the urine spot protein/creatinine ratio a valid diagnostic test for pre-eclampsia? , 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[41] J. Roberts,et al. Endothelial Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[42] K. Zerres,et al. Genes and the preeclampsia syndrome , 2008, Journal of perinatal medicine.
[43] R. T. Lie,et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.
[44] J. D. Neill,et al. The Physiology of reproduction , 1988 .
[45] Robert N. Taylor,et al. Angiogenesis and Preeclampsia , 2012, Chesley's Hypertensive Disorders in Pregnancy.
[46] T. Shike,et al. Animal models. , 2001, Contributions to nephrology.
[47] Santosh A. Khedkar,et al. Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia , 2011, Circulation.
[48] A. Sedman,et al. Angiotensin-converting enzyme inhibitor fetopathy. , 1993, Journal of the American Society of Nephrology : JASN.
[49] G. Dekker,et al. Prediction of pregnancy‐induced hypertensive disorders by angiotensin II sensitivity and supine pressor test , 1990, British journal of obstetrics and gynaecology.
[50] S. Karumanchi,et al. Preeclampsia and the Anti-Angiogenic State. , 2011, Pregnancy hypertension.
[51] L. Vatten,et al. Pre-eclampsia in pregnancy and subsequent risk for breast cancer , 2002, British Journal of Cancer.
[52] A. Benigni,et al. Mapping the Theories of Preeclampsia and the Role of Angiogenic Factors: A Systematic Review , 2007, Obstetrics and gynecology.
[53] E. Begg,et al. Concentrations of beta-blocking drugs in human milk. , 1990, The Journal of pediatrics.
[54] D. Arduini,et al. Effects of nifedipine on umbilical artery velocity waveforms in healthy human fetuses. , 1987, Gynecologic and obstetric investigation.
[55] D. Lewis,et al. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. , 2008, The Journal of clinical endocrinology and metabolism.
[56] W. White. Management of hypertension during lactation. , 1984, Hypertension.
[57] S. Chand,et al. A clinical test useful for predicting the development of acute hypertension in pregnancy. , 1974, American journal of obstetrics and gynecology.
[58] E. Burgess,et al. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[59] T. Musci,et al. Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.
[60] R. Ehrenkranz,et al. Nifedipine transfer into human milk. , 1989, The Journal of pediatrics.
[61] J. Granger,et al. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. , 2006, Methods in molecular medicine.
[62] B. Mol,et al. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[63] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.
[64] D. Henderson-smart,et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.
[65] R. Kendall,et al. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[66] L. Magee. Drugs in pregnancy. Antihypertensives. , 2001, Best practice & research. Clinical obstetrics & gynaecology.
[67] J. Kooner,et al. Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.
[68] M. Hadders‐Algra,et al. Is clonidine a behavioural teratogen in the human? , 1986, Early human development.
[69] S. Blackwell,et al. Angiotensin Receptor Agonistic Autoantibody Is Highly Prevalent in Preeclampsia: Correlation With Disease Severity , 2010, Hypertension.
[70] G. Lip,et al. Effect of atenolol on birth weight. , 1997, The American journal of cardiology.
[71] W. Raab,et al. Vascular reactivity and electrolytes in normal and toxemic pregnancy; pathogenic considerations and a diagnostic pre-toxemia test. , 1956, The Journal of clinical endocrinology and metabolism.
[72] E. M. Symonds,et al. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. , 1989, British journal of obstetrics and gynaecology.
[73] C. Berg,et al. Pregnancy‐Related Mortality From Preeclampsia and Eclampsia , 2001, Obstetrics and gynecology.
[74] V. Apgar,et al. DRUGS IN PREGNANCY. , 1965, JAMA.
[75] N. Wasserstrum. Nitroprusside in Preeclampsia Circulatory Distress and Paradoxical Bradycardia , 1991, Hypertension.
[76] R. Kauffman,et al. Transfer of drugs and other chemicals into human milk. , 1989, Pediatrics.
[77] S. Lindow,et al. The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension. , 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[78] B. Sibai,et al. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. , 1991, American journal of obstetrics and gynecology.
[79] R. Carr-Hill,et al. Pre‐eclampsia in second pregnancy , 1985 .
[80] G. A. D. Gynaecologist. Prediction of pregnancy-induced hypertensive disorders by angiotensin II sensitivity and supine pressor test , 2005 .
[81] E. Seely,et al. Clinical practice. Chronic hypertension in pregnancy. , 2011, The New England journal of medicine.
[82] S. Lindow,et al. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy , 1988, British journal of obstetrics and gynaecology.
[83] Harpar S. Buttar. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development , 1997, Molecular and Cellular Biochemistry.
[84] G. Massicotte,et al. Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats. , 1985, Life sciences.
[85] F. Hisaw. Experimental relaxation of the pubic ligament of the guinea pig. , 1926 .
[86] L. Butters,et al. First year of life after the use of atenolol in pregnancy associated hypertension. , 1984, Archives of disease in childhood.
[87] Lewis H Kuller,et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. , 2004, American journal of physiology. Heart and circulatory physiology.
[88] G. Stoddard,et al. Preeclampsia and subsequent risk of cancer in Utah. , 2006, American journal of obstetrics and gynecology.
[89] R. Jeremy,et al. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. , 2002, American journal of physiology. Heart and circulatory physiology.
[90] J. Davison,et al. Overview: Kidney Function in Pregnant Women , 1987 .
[91] B. Sibai,et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. , 2010, American journal of obstetrics and gynecology.
[92] M. Varner,et al. Paternal and maternal components of the predisposition to preeclampsia. , 2001, The New England journal of medicine.
[93] G. Wallukat,et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. , 1999, The Journal of clinical investigation.
[94] H. V. van Geijn,et al. Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[95] D. James,et al. Pre‐eclampsia and trisomy 13 , 1992, British journal of obstetrics and gynaecology.
[96] S. Shroff,et al. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats. , 2004, Endocrinology.
[97] P. Siiteri,et al. Placental characteristics and reduced risk of maternal breast cancer. , 2001, Journal of the National Cancer Institute.
[98] M. de Swiet,et al. The management of postpartum hypertension , 2002, BJOG : an international journal of obstetrics and gynaecology.
[99] B. Sibai,et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.
[100] B. Sibai,et al. Pregnancy Outcomes in Healthy Nulliparas Who Developed Hypertension , 2000, Obstetrics and gynecology.
[101] A. Pastuszak,et al. Drugs in pregnancy. , 1998, The New England journal of medicine.
[102] N. Wessel,et al. Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion , 2007, Hypertension.
[103] J. Hall. Vascular reactivity and electrolytes in normal and toxemic pregnancy , 1957 .
[104] B. Sibai,et al. Magnesium Sulfate in Women With Mild Preeclampsia: A Randomized Controlled Trial , 2003, Obstetrics and gynecology.
[105] W. Holzgreve,et al. Reproductive Biology and Endocrinology Open Access Potential Markers of Preeclampsia – a Review , 2022 .
[106] E. Widerlöv,et al. Hydralazine-induced neonatal thrombocytopenia. , 1980, The New England journal of medicine.
[107] V. Garovic. The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension. , 2012, Hypertension.
[108] K. Khan,et al. How useful is uterine artery Doppler flow velocimetry in the prediction of pre‐eclampsia, intrauterine growth retardation and perinatal death? An overview , 2000, BJOG : an international journal of obstetrics and gynaecology.
[109] C. Johnson,et al. A sister's risk: family history as a predictor of preeclampsia. , 2005, American journal of obstetrics and gynecology.
[110] M. Rönnback,et al. Impaired vascular dilatation in women with a history of pre-eclampsia , 2006, Journal of hypertension.
[111] R. Liston,et al. Random Protein‐Creatinine Ratio for the Quantitation of Proteinuria in Pregnancy , 1997, Obstetrics and gynecology.
[112] S. Vreeburg,et al. Hypertension during pregnancy in South Australia, Part 1: Pregnancy outcomes , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.
[113] H. Odendaal,et al. Serotonin Antagonism and Serotonin Antagonists in Pregnancy: Role of Ketanserin , 2000, Obstetrical & gynecological survey.
[114] A. Hunter,et al. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. , 2004, American journal of obstetrics and gynecology.
[115] M. Bennett,et al. Phaeochromocytoma in pregnancy. , 1959, Lancet.
[116] B. Sibai,et al. Prediction and prevention of recurrent preeclampsia. , 2008, Obstetrics and gynecology.
[117] R. Kaaja,et al. Insulin resistance and sympathetic overactivity in women. , 2006, Journal of hypertension.
[118] L. Impey. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks , 1993, British journal of obstetrics and gynaecology.
[119] S. Maynard,et al. Angiogenic factors and preeclampsia. , 2011, Seminars in nephrology.
[120] K. Conrad. Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia. , 2011, Seminars in nephrology.
[121] P. August,et al. Update on the use of antihypertensive drugs in pregnancy. , 2008, Hypertension.
[122] Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy , 2008 .
[123] R. Romero,et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[124] S. Hernández-Díaz,et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.
[125] K. Khan,et al. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis , 2008, BMJ : British Medical Journal.
[126] S. Kennedy,et al. Atenolol in essential hypertension during pregnancy. , 1990, BMJ.
[127] J. Soustiel,et al. The effect of isosorbide dinitrate, a donor of nitric oxide, on maternal cerebral blood flow in gestational hypertension and preeclampsia. , 2003, American journal of obstetrics and gynecology.
[128] S. Chand,et al. A study of angiotensin II pressor response throughout primigravid pregnancy. , 1973, The Journal of clinical investigation.
[129] A. Skrondal,et al. Recurrence risk of preeclampsia in twin and singleton pregnancies , 2004, American journal of medical genetics. Part A.
[130] G. ter Riet,et al. Accuracy of serum uric acid determination in predicting pre‐eclampsia: A systematic review , 2006, Acta obstetricia et gynecologica Scandinavica.
[131] B. Corenblum,et al. Spironolactone therapy during human pregnancy. , 1995, American journal of obstetrics and gynecology.
[132] L. Florea,et al. Novel splice variants of sFlt1 are upregulated in preeclampsia. , 2009, Placenta.
[133] K. Lim,et al. Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.
[134] B. Sibai,et al. Mild gestational hypertension remote from term: progression and outcome. , 2001, American journal of obstetrics and gynecology.
[135] D. Kallogjeri,et al. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. , 2008, American journal of obstetrics and gynecology.
[136] J. Catov,et al. First trimester uric acid and adverse pregnancy outcomes. , 2011, American journal of hypertension.
[137] Donna D. Johnson,et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. , 2006, American journal of obstetrics and gynecology.
[138] B. Sibai,et al. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. , 1986, American journal of obstetrics and gynecology.
[139] R. Abdul-karim,et al. Pressor response to angiotonin in pregnant and nonpregnant women. , 1961, American journal of obstetrics and gynecology.
[140] F. Corrado,et al. Endoglin, PlGF and sFlt‐1 as markers for predicting pre‐eclampsia , 2008, Acta obstetricia et gynecologica Scandinavica.
[141] N. Wessel,et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. , 2008, American journal of obstetrics and gynecology.
[142] R. Peto,et al. Overview of randomised trials of diuretics in pregnancy. , 1985, British medical journal.
[143] B. Sibai,et al. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. , 1992, American journal of obstetrics and gynecology.